Announce Date | 04/23/2025 |
EPS Normalized Actual | $0.76 (Miss by $-0.19) |
EPS GAAP Actual | $0.76 (Miss by $-0.19) |
Revenue Actual | $1.96439B |
Revenue Surprise | Beat by $1964.39M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 11.16 | 7.4 | 10.51114 | 11.80803 | 7 |
Dec 2028 | 15.46 | 5.34 | 13.6091 | 16.44183 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.67 | 0.67 | 1.96439B | 5.19% | 1964.39M |
FQ4 2024 (Dec 2024) | 0 | 0 | 2.07689B | 5.21% | 2076.89M |
FQ3 2024 (Sep 2024) | 1.52 | 1.52 | 2.20216B | 13.22% | 2202.16M |
FQ2 2024 (Jun 2024) | 1.39 | 1.39 | 2.26408B | 20.88% | 2264.08M |
FQ1 2024 (Mar 2024) | 1.09 | 1.09 | 1.86246B | 0.66% | 1862.46M |
FQ4 2023 (Dec 2023) | 0 | 0 | 1.96868B | 100% | 1968.68M |
FQ3 2023 (Sep 2023) | 1.55 | 1.55 | 1.91105B | 100% | 1911.05M |
FQ2 2023 (Jun 2023) | 1.49 | 1.49 | 1.79127B | 100% | 1791.27M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.4268 | -- | 3.29794 | 3.61088 | 1 |
FQ3 2027 (Sep 2027) | 3.0941 | -- | 2.58565 | 3.3303 | 8 |
FQ2 2027 (Jun 2027) | 3.019 | -- | 2.52289 | 3.24946 | 5 |
FQ1 2027 (Mar 2027) | 2.6658 | -- | 2.56556 | 2.809 | 1 |
FQ4 2026 (Oct 2026) | 2.67463 | -- | 2.42228 | 2.83027 | 3 |
FQ3 2026 (Jul 2026) | 2.4858 | -- | 2.25126 | 2.63045 | 3 |
FQ2 2026 (Jun 2026) | 2.70913 | -- | 2.4074 | 3.00076 | 3 |
FQ1 2026 (Mar 2026) | 2.2087 | 69.67 | 2.12565 | 2.32735 | 1 |
FQ4 2025 (Oct 2025) | 2.37451 | -- | 2.15047 | 2.51268 | 4 |
FQ3 2025 (Jul 2025) | 2.2224 | 31.61 | 2.01272 | 2.35172 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.96B | -- | 2.88B | 3.08B | 1 |
FQ3 2027 (Sep 2027) | 2.92B | -- | 2.55B | 3.09B | 4 |
FQ2 2027 (Jun 2027) | 2.85B | -- | 2.49B | 3.01B | 6 |
FQ1 2027 (Mar 2027) | 2.76B | -- | 2.68B | 2.88B | 1 |
FQ4 2026 (Oct 2026) | 2.59B | -- | 2.4B | 2.7B | 4 |
FQ3 2026 (Jul 2026) | 2.56B | -- | 2.38B | 2.68B | 5 |
FQ2 2026 (Jun 2026) | 2.6B | -- | 2.37B | 2.81B | 4 |
FQ1 2026 (Mar 2026) | 2.46B | 20.3 | 2.39B | 2.57B | 1 |
FQ4 2025 (Oct 2025) | 2.43B | 14.42 | 2.25B | 2.54B | 2 |
FQ3 2025 (Jul 2025) | 2.37B | 7 | 2.2B | 2.47B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
0
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.67 | 0.67 | 100% | |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 1.52 | 1.52 | 100% | |
FQ2 2024 (Jun 2024) | 1.39 | 1.39 | 100% | |
FQ1 2024 (Mar 2024) | 1.09 | 1.09 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 1.55 | 1.55 | 100% | |
FQ2 2023 (Jun 2023) | 1.49 | 1.49 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.96B | $1964.39M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.08B | $2076.89M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.2B | $2202.16M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.26B | $2264.08M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.86B | $1862.46M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.97B | $1968.68M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.91B | $1911.05M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.79B | $1791.27M | 100% |